Item 8.01 Other Events.
On January 5, 2021, Aerpio Pharmaceuticals, Inc. issued a press release titled
"Aerpio Announces Strategic Review after Topline Results from Razuprotafib
Glaucoma Phase 2 Trial." A copy of the press release is attached hereto as
Exhibit 99.1 and is incorporated into this Item 8.01 by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press release issued by Aerpio Pharmaceuticals, Inc. on
January 5, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses